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Irish Injecting Drug Users and Hepatitis C: Importance of the social context of injecting 
Bobby P Smyth, Joe Barry, Eamon Keenan 
 
Summary 
 
Background. The incidence of hepatitis C (HCV) infection among injecting drug users (IDU) 
in Dublin is particularly high by international standards. The most robust predictor of an 
IDU’s HCV status is their total number of lifetime injecting episodes. It is proposed that 
participation in specific unsafe injecting practices is the principal contributor to this 
accumulated risk. We sought to test this hypothesis. The relationship between social context 
of injecting and HCV status was also examined.  
Methods. We conducted a cross-sectional survey of IDU recruited from treatment settings in 
Dublin. Participants had injected in the preceding six months and had not previously been 
tested for HCV. A structured interview was administered. 
Results. HCV testing was performed on 159 IDU and 61% were antibody positive. The three 
characteristics that were significant independent predictors of a positive test result were 
increased total number of lifetime injecting episodes, closer social relationships with other 
IDU and injecting in the home of other IDU. Frequency of recipient syringe sharing, 
backloading and sharing of injecting paraphernalia were not independently associated with 
infection.  
Conclusions. We found that the robust association between HCV infection and number of 
lifetime injecting episodes was not explained by increased unsafe injecting practices. The 
socialised nature of heroin injecting in Dublin is contributing to the HCV epidemic in this 
population. These findings suggest that accidental and unnoticed sharing of injecting 
equipment may be an important contributor to an IDU’s increasing risk of infection over time.  
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Key Messages 
 
 Hepatitis C (HCV) status among injecting drug users (IDU) is strongly correlated with 
their total number of lifetime injecting episodes. 
 Self-reported unsafe injecting practices, such as recipient syringe sharing, are not 
strong predictors of HCV status. 
 IDU who are in intimate relationships with other IDU are at increased risk of HCV 
infection. 
 IDU should use a new sterile syringe on each injecting occasion. 
 If IDU choose to re-use a syringe, they should take great care to ensure that it does not 
become accidentally mixed up with the injecting equipment of other IDU. 
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Introduction 
 
Injecting drug users (IDU) are at high risk for hepatitis C (HCV) infection [1,2]. In studies 
examining the prevalence of HCV in populations of IDU, duration of injecting and the 
frequency of injecting each day are the factors most consistently associated with infection [3-
13]. Numerous studies measuring the incidence of HCV infection among IDU have found that 
increased frequency of injecting is associated with seroconversion [9, 14-16]. Overall, this 
body of research confirms that an IDUs risk of exposure to HCV increases as their number of 
lifetime injecting episodes increase [17].  
 
Injecting drugs does not cause HCV infection in itself. It is engagement in unsafe injecting 
practices which permits the parenteral spread of this virus. Specific injecting practices such as 
borrowing used syringes from other IDU (recipient syringe sharing), backloading  and the 
sharing of ‘cookers’ and filters constitute unsafe injecting practices. (Backloading involves 
the preparation of heroin in one syringe and subsequent transfer of half the contents to a 
different syringe). Many studies have demonstrated an association between these practices 
and HCV infection [3-6, 15]. It has been proposed that engagement in these specific overt risk 
behaviours is the principal contributor to an individual’s risk of HCV infection [1]. If this 
assertion is correct, accurate measurement of unsafe injecting episodes should predict HCV 
status more robustly than measurement of total number of lifetime injecting episodes.  
 
The social context in which IDU inject has also been linked with HCV status [18]. IDU who 
inject in company and those who are injected by someone else have been demonstrated to be 
at increased risk of infection [3,5]. IDU who are in a sexual relationship with another IDU are 
more likely to engage in unsafe injecting practices and may be at increased risk of HCV 
Please use the following citation: Smyth BP (2005) Irish injecting drug users and hepatitis C: importance of the social context of 
injecting (Author postprint) in International Journal of Epidemiology, 34 (1). pp. 166-172. [Accessed: (date) from 
www.drugsandalcohol.ie]   
   5 
infection [13, 19, 20]. A number of researchers have reported that settings in which there is 
reduced access to sterile injecting equipment, particularly prisons, are associated with 
increased risk of HCV infection [6,8]. 
 
In Dublin, the prevalence and incidence of HCV among IDU has been demonstrated to be 
particularly high by international standards. The incidence of HCV infection has been found 
to be 66 infections per 100 person years at risk [16]. High rates of infection have been 
matched by high rates of self-reported risk behaviour [20, 21]. Seventy per cent of IDU 
reported recent recipient syringe sharing, while 87% reported sharing of drug injecting 
paraphernalia such as spoons and filters [20]. Recipient syringe sharing was found to be 
significantly associated with less education, parental unemployment, polydrug injecting, 
injecting in company, perceiving less danger in sharing and having more intimate 
relationships with other IDU. This highlights the importance of social context in influencing 
risk behaviour in Dublin. Despite frequent unsafe injecting and a high prevalence of HCV 
infection, the incidence and prevalence of HIV infection were very low in the mid-1990s [7, 
16]. Among IDU who had been injecting for up to five years, only 0.6% were HIV positive. 
However, there has been some evidence of a recent increase in HIV incidence in, with many 
new cases occurring in clusters of young IDU [22].  
 
In view of the important contribution made by social circumstances in influencing HCV rates 
among IDU and the particularly high incidence of HCV in Dublin, some further description of 
the drug using culture in Dublin is warranted to put the current study in context. The heroin 
using population in Dublin is very young by European standards [23]. Most IDU spend some 
time chasing (smoking) heroin prior to injecting. Heroin is ‘cooked’ on spoons in preparation 
for injecting. Most IDU come from materially deprived backgrounds and continue to live at 
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home with their family of origin [24]. Socially, they tend to aggregate into loosely bound but 
identifiable clusters [22]. Addiction treatment services expanded substantially during the early 
1990s, greatly increasing access to methadone treatment. By 1996, there were 13 syringe 
exchange programs in the city. Plans to open further syringe exchanges have met with very 
substantial local community resistance. Communities reported concerns that children would 
pick up discarded needles and worried that syringes would be used as weapons in robberies. 
No syringe exchange provides 24-hour access. The number of outreach workers increased 
during the 1990s. They offer advice on safe injecting, provide syringe exchange directly to 
IDU and facilitate treatment entry. 
 
In this study we sought to examine factors associated with HCV status among IDU in Dublin. 
We hypothesised that frequency of unsafe injecting practices would predict HCV status more 
robustly than number of lifetime injecting episodes. Secondly, we hypothesised that the social 
context in which IDU injected would influence their HCV status. 
 
 
Method 
 
The patients in this study were drawn from a number of different treatment settings in Dublin. 
These settings included the two inpatient drug dependency units and the largest outpatient 
drug treatment centre. Patients were also recruited from seven smaller treatment centres. 
These smaller treatment centres were selected on the basis of interest in the research being 
expressed by the lead clinician at these sites. Patients were eligible to participate if they had 
not previously been tested for HCV and they had a history of injecting in the previous six 
months. These patients were routinely offered HCV testing as part of their overall treatment 
Please use the following citation: Smyth BP (2005) Irish injecting drug users and hepatitis C: importance of the social context of 
injecting (Author postprint) in International Journal of Epidemiology, 34 (1). pp. 166-172. [Accessed: (date) from 
www.drugsandalcohol.ie]   
   7 
package. When the interviewer visited the treatment site, clinical staff identified new patients 
who met the inclusion criteria. A structured interview was administered to IDU who 
consented to participate in the study, before they underwent HCV testing. The structured 
interview was adapted from that used in a WHO study [25]. The lead author (BPS) conducted 
all interviews. This interview provides detailed information on injecting behaviour during the 
preceding six months. Patients reported (i) the number of months during which they injected, 
(ii) the typical number of days per month on which they injected and (iii) the average number 
of injecting episodes which occurred on an injecting day. The number of injecting episodes in 
the six month period was the product of these three variables. Patients then estimated the 
frequency that they engaged in the specific unsafe injecting behaviours during the preceding 
six months (e.g. using another IDU’s spoon every second injecting occasion and recipient 
syringe sharing one in every ten injecting episodes).The number of these episodes was 
calculated by multiplying the proportion (e.g. ½ or 1/10) by the number of injecting episodes 
in the past six months.  
 
In order to estimate the total number of lifetime injecting episodes, we asked participants to 
state when they first injected. If they had been injecting for more than six months, they were 
asked to report any previous periods during which their injecting frequency was increased or 
decreased due to factors such as abstinence, reverting to heroin smoking or receipt of 
methadone treatment. If such periods were reported, they were taken into account when 
estimating the number of lifetime injecting episodes. 
 
Recipient syringe sharing was specifically explored as suggested by McKegney & Bernard , 
i.e. we ensured that we distinguished between borrowing a needle or syringe from another 
IDU versus lending an item to another IDU [26]. When not directly examined, IDU may 
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under-report recipient syringe sharing with their spouse or regular sexual partner. 
Consequently, we explored recipient syringe sharing across the range of categories of social 
relationships including strangers, acquaintances, close friends and their spouse, girlfriend or 
boyfriend. We did not examine other unsafe injecting behaviours in the same detail across 
these social relationships.  
 
Consenting patients for HCV testing, conducting of testing and informing them of test results 
remained the clinical responsibility of the doctor at their clinic. No tests were conducted for 
purely research purposes.  
 
The screening test for HCV was a third generation enzyme linked immunosorbant assay 
(EIA) for antibody to HCV ( Ortho Diagnostics, Amersham, Buckinghamshire, England ). All 
positive results were confirmed with an additional EIA. A recombinant immunoblot assay 
was used in situations where the two EIA gave contradictory results. The initial screen for 
HIV was with two EIA tests for antibody to HIV. Positive tests were confirmed with the 
Western blot assay. 
 
 
Statistical Analysis 
 
Associations between categorical variables and HCV status were examined using Pearson’s 
chi square test. Odds ratio and their 95% confidence intervals were reported to indicate the 
magnitude and direction of associations. For the purposes of data presentation and statistical 
analysis, quantitative variables were converted into categories and associations with HCV 
status were subsequently explored via Mantel-Haenszel chi square test for trend. These same 
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statistical tests were also used to examine for association between variables and completion of 
HCV testing.  
 
When conducting power calculations, we examined our ability to detect significant 
associations between HCV and strong predictors of infection (odds ratio 3.0), and also with 
moderate predictors of infection (odds ratio 2.0). The level of statistical significance was set 
at 0.05. We anticipated completing HCV testing on 160 interviewees and this meant that we 
had 90% power to detect strong predictors of infection and 50% power to detect moderate 
predictors. 
 
To test the hypothesis that injecting related variables would predict HCV status independently 
of total number of lifetime injections, each variable was separately entered into a logistic 
regression equation along with ‘lifetime injecting episodes’. The Wald statistic was utilised to 
derive p values.  
 
A logistic regression analysis was conducted to identify those variables independently 
predictive of HCV status. All variables examined on univariate analysis were considered for 
selection into the final regression equation. Variables were chosen by using the forward and 
backward selection techniques. The selected variables were examined for evidence of 
interaction. The variance in observed outcome explained by the regression equation was 
calculated using the Nagelkerke R2 value [27]. 
 
 
Results 
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Only two of the patients approached to participate in the interview refused. Among the 242 
patients interviewed, 159 (66%) underwent HCV testing and our analysis focused on this 
latter group. Males accounted for 58% of this group. The median age of participants was 21 
years (interquartile range [IQR] 19 to 25 years) and median time since commencement of 
injecting was 22 months ( IQR 9 to 38 ). Sixty-seven per cent reported injecting every day. 
Heroin was the main drug injected by 155 (97%) participants. Compared to those who failed 
to undergo HCV testing following interview, the group who underwent testing reported 
increased recipient syringe sharing (p=0.04) and increased backloading (p=0.04). Undergoing 
testing was also significantly associated with younger age (p=0.03), parental employment 
(p=0.03) and a lower perception of danger in borrowing a syringe (p=0.01). One hundred and 
thirty nine (87%) of the patients tested for HCV also underwent HIV testing. All of these 
patients tested negative for HIV antibodies. 
 
Ninety-seven (61%) participants tested positive for HCV antibodies. The associations 
between HCV status and injecting variables, including unsafe injecting practices, are reported 
in Table 1. Testing positive for HCV was significantly associated with the number of lifetime 
injecting episodes. On univariate analysis, it was also significantly associated with the 
duration of the injecting career, the number of different substances injected, the number of 
episodes of sharing spoons and filters and the number of episodes of backloading in the 
preceding six months. None of these associations remained significant when we controlled for 
the confounding effect of ‘number of lifetime injecting episodes’ in the logistic regression 
analysis. HCV status was not associated with any of the other injecting variables examined. 
Specifically, there was no significant association between infection and the number of 
episodes of recipient syringe sharing.  
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Table 1. Association between hepatitis C status and quantitative injecting variables 
    Hepatitis C Positive Univariate analysis Adjusted for total lifetime 
injection episodes 
     
Number 
 
Number % x2 trend p value 
Wald 
statistic p value 
        
Lifetime Injecting        
         
 Number of lifetime injecting episodes        
  1-100 28 8 29     
  101-1000 48 28 58     
  1001+ 83 61 73 17.2 <0.001   
          
 Duration of injecting career        
  Less than 12 months 49 26 53     
  12 to 59 months 86 52 60     
  Five years or more 23 19 83 5.0 0.03 0.05 0.82 
          
 Delay between first opiate use and first injecting        
  Less than 12 months 42 30 71     
  12 to 36 months 53 32 60     
  More than 36 months 50 28 56 2.2 0.13 0.07 0.79 
          
Injecting behaviours in past six months        
          
 Usual number of IDU in company when injecting        
  None (injects alone) 28 18 64     
  One 56 33 59     
  Two or more 31 20 65 0.002 0.97 0.6 0.45 
          
 Number of substances injected        
  One 50 23 46     
  Two 58 36 62     
  Three or more 51 38 75 8.6 0.003 1.9 0.17 
          
 Average number of times each syringe is used        
  Once only 16 8 50     
  Two or three times 38 24 63     
  Four to ten times 52 27 52     
  More than ten times 52 37 71 1.7 0.19 0.27 0.60 
          
 Number of episodes of recipient syringe sharing        
  None 38 21 55     
  1 – 10 60 33 55     
  11 – 100 46 33 72     
  101 or more 15 10 67 2.4 0.12 0.60 0.42 
          
 Number of episodes of using a spoon or filter 
which had been already used another injector 
       
  None 16 8 50     
  1 – 10 24 8 33     
  11 – 100 38 23 61     
  101 or more 69 51 74 9.7 0.002 2.8 0.10 
          
 Number of episodes of backloading        
  None 36 17 47     
  1 – 10 16 9 56     
  11 – 100 29 20 69     
  101 or more 14 11 79 5.5 0.02 2.9 0.09 
          
 Number of people from whom borrowed syringes         
  None 36 19 53     
  One 53 32 60     
  Two or more 56 38 68 2.1 0.15 1.8 0.18 
          
Beliefs about risk behaviours        
          
 Perceived risk in borrowing a used syringe from an 
acquaintance 
       
  Very High 70 38 54     
  Moderately High 36 25 69     
  Lower 48 31 65 1.5 0.22 0.42 0.52 
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The association between HCV status and socio-demographic and other categorical injecting 
variables are reported in table 2. Those IDU who described their closest relationship with 
another IDU as being no more than an ‘acquaintance’ were at significantly reduced risk of 
HCV infection compared to those who described other IDU as their close friends or 
spouse/boyfriend/girlfriend. HCV status was unrelated to any other socio-demographic 
characteristic. Self reported difficulty in accessing sterile injecting equipment and failure to 
use bleach were not significantly associated with infection.  
Table 2. Association between hepatitis C and categorical socio-demographic and injecting variables 
    HCV Positive Univariate Analysis 
   Number Number % Odds Ratio (OR) 95% CI of OR p value 
Socio-Demographic Characteristics       
 Gender       
  Male 93 54 58 1.0   
  Female 66 43 65 1.3 0.7 – 2.6 0.37 
         
 Age (Years)       
  21 and below 83 49 59 1.0   
  22 and over 76 48 63 1.2 0.6 – 2.3 0.60 
         
 Employment       
  Working 33 79 55 1.0   
  Unemployed 126 18 63 1.4 0.6 – 3.0 0.39 
         
 Accommodation Stability       
  Stable 143 88 62 1.0   
  Unstable (Temporary or many moves) 16 9 56 0.8 0.3 – 2.3 0.68 
         
 Education       
  Left school aged 15 or older 119 72 61 1.0   
  Left school aged 14 or younger 40 25 63 1.1 0.5 – 2.3 0.82 
         
 Parental Employment       
  Employed 90 56 62 1.0   
  Unemployed 53 31 58 0.9 0.4 – 1.7 0.66 
         
Lifetime injecting       
 Injecting in Prison       
  Never 141 84 60 1.0   
  Yes 18 13 72 1.8 0.6 – 5.2 0.3 
         
Past six months of injecting       
 Accessibility to sterile injecting equipment       
  Difficult to access 48 26 54 0.7 0.3 – 1.4 0.28 
  Not difficult to access 109 69 63 1.0   
         
 Usual Location when injecting       
  Own home or in a non-IDU’s home 63 33 52 1.0   
  Home of another IDU 31 22 71 2.2 0.9 – 5.6 0.09 
  Elsewhere or many locations 64 42 66 1.7 0.8 – 3.5 0.13 
         
 Closest relationship with another injector       
  Spouse, girlfriend, boyfriend 51 35 69 3.5 1.3 – 9.4 0.01 
  Close friend or sibling 82 52 63 2.8 1.1 – 6.9 0.02 
  Acquaintance 26 10 38 1.0   
         
 Bleach cleaning of borrowed syringes       
  Borrowed but always used bleach 27 19 70 1.0   
  Borrowed and didn’t always use bleach 92 56 61 0.7 0.3 – 1.7 0.37 
  Never borrowed syringes 38 21 55 0.5 0.2 – 1.5 0.22 
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Following forward and backward selection procedures, three variables were selected for entry 
into the logistic regression equation. The results are reported in table 3. It emerged that 
greater number of lifetime injecting episodes, closer social relationships with other IDU and 
injecting in the home of other IDU were each independently predictive of HCV positive 
status. There was no evidence of interaction between the variables. The Nagelkerke R2 value 
was 0.24. 
 
Given the international evidence supporting an association between duration of injecting 
career and HCV status, we entered this variable into the regression equation both with and 
without ‘number of lifetime injecting episodes’ in a post hoc analysis. It did not significantly 
improve the fit of the model. There was no evidence of a significant interaction with ‘number 
of lifetime injecting episodes’. 
 
Table 3. Multiple variable analysis of factors associated with HCV infection 
  Adjusted Odds 
Ratio (AOR) 
95% C.I. of AOR p value 
     
Number of lifetime injecting episodes    
 1 – 100 1.0   
 101 – 1000 3.8 1.3 – 11.6 0.02 
 More than 1000 8.7 2.9 – 25.9 <0.001 
     
Usual location when injecting    
 Own home or in a non-IDU’s home 1.0   
 Home of another IDU 4.7 1.5 – 14.4 0.007 
 Elsewhere or many locations 1.8 0.8 – 3.9 0.15 
     
Closest relationship with another injector    
 Spouse, girlfriend, boyfriend 3.4 1.1 – 10.2 0.03 
 Close friend or sibling 2.8 1.0 – 7.7 0.04 
 Acquaintance 1.0   
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Discussion 
 
HCV status was strongly associated with the total number of lifetime injecting episodes, with 
the odds ratio of infection increasing approximately by three for each ten-fold increase in 
number of lifetime injecting episodes. This finding was expected and is consistent with the 
international literature. It emerged that the detected association between HCV infection and 
unsafe injecting practices was quite tenuous. Although infection was associated with 
increased frequency of backloading and with increased frequency of sharing of injecting 
paraphernalia, no association was found with recipient syringe sharing. Other investigators 
have also experienced greater success in identifying associations between HCV and 
behaviours such as backloading and the sharing of filters than between HCV and recipient 
syringe borrowing [3, 6, 15]. In any case, the associations between each of these former two 
practices and HCV infection was lost when analysis controlled for ‘number of lifetime 
injecting episodes’. This replicated the finding of Garfein et al. who noted that significant 
associations between HCV and risk behaviours on univariate analysis, did not persist when 
controlled for length of injecting history [3]. We therefore failed to confirm our hypothesis 
that frequency of engagement in specific unsafe injecting practices would predict HCV status 
more robustly than total number of lifetime injecting episodes.  
 
There are important methodological reasons that may have contributed to our failure to 
confirm this hypothesis. Firstly, IDU may choose to under-report engagement in unsafe 
injecting practices, making significant associations more difficult to detect. However, the 
proportion of IDU reporting unsafe injecting was high by international standards and there is 
general consensus that IDU do reliably report such behaviours in studies of this type [28, 29]. 
Secondly, unsafe injecting behaviours were measured in the six months prior to interview 
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rather than over the interviewee’s entire injecting career. We opted to focus on this six month 
period in order to maximise the possibility of accurate recall, replicating methods used in 
other studies of this type. It is possible that frequency of recent unsafe injecting may differ 
substantially from rates of unsafe injecting early in an IDU’s history. Thirdly, although this 
study had acceptable power to identify characteristics strongly associated with HCV infection, 
it had only 50% power to detect factors moderately associated with infection.  
 
Apart from methodological considerations, there is one intriguing possible clinical 
explanation for our finding that self-reported rates of unsafe injecting poorly predict HCV 
status. IDU can only report episodes of unsafe injecting which they have noticed. Researchers 
in Australia and Scotland have demonstrated that there is much opportunity for inadvertent, 
accidental and unnoticed sharing of injecting equipment, particularly when IDU inject in the 
company of others [2, 30, 31]. Consequently, during an IDU’s injecting career, their risk of 
acquiring HCV, or indeed HIV, will be the sum of the risk associated with engagement in 
overtly noticed unsafe injecting episodes plus the risk associated with unnoticed, or covert, 
unsafe injecting practices. If the latter occur more frequently than the former in this era of 
harm reduction, then reported rates of unsafe injecting will correlate poorly with HCV status.  
 
It emerged that the total number of lifetime injecting episodes predicted HCV status more 
accurately than duration of injecting career. The latter variable does not take into account the 
fluctuations in injecting frequency which can occur over time. Most of the IDU in this study 
had short injecting histories and this simplified the estimation process. Calculation of lifetime 
injecting episodes would be more difficult in studies examining IDU with longer injecting 
histories. 
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It emerged that HCV status was significantly associated with aspects of the social context in 
which IDU injected. Those patients who reported closer social relationships with other IDU 
were at increased risk of infection. Research in Dublin and elsewhere has shown that IDU are 
more likely to engage in recipient syringe sharing with other IDU whom they know well, such 
as their spouse, girlfriend or boyfriend [19, 20, 32]. Those IDU who usually injected in the 
home of another IDU were also more likely to test positive for HCV antibodies. We found 
that the majority of IDU use each syringe on at least four occasions. This suggests that most 
IDU will usually have used syringes on their person or among their belongings. This increases 
the opportunity for both deliberate and accidental sharing of syringes, particularly if injecting 
in the social contexts that we identified as being significantly associated with infection, i.e. 
away from one’s own home and with close friends. Unfortunately, drug injecting in Dublin is 
a very socialised behaviour among young IDU, and commonly occurs in exactly such a 
setting. 
 
 
Conclusions 
 
The association between HCV and specific overt unsafe injecting behaviours was not strong. 
Overall, we found that the total number of lifetime injecting episodes was the most important 
predictor of HCV status. These findings suggest that interventions that reduce injecting are 
likely to have a greater impact on HCV prevention than interventions designed to make 
injecting safer. Methadone maintenance is effective in reducing injecting but novel 
interventions to prevent or reverse the transition from heroin smoking to injecting warrant 
further examination [2]. The other independent predictors of HCV infection related to the 
social context in which IDU inject. This finding also has important implications for harm 
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reduction programs. While clinicians and staff at syringe exchanges need to ensure attention 
continues to be paid to unsafe injecting practices, greater attention should be directed towards 
the setting and context in which the individual IDU injects. There is a need for discussion 
with IDU about how they ensure that their syringes and injecting equipment do not become 
mixed up with the equipment of other IDU when injecting in company. This might serve to 
raise awareness of the possibility of accidental and unnoticed sharing of injecting equipment 
and thereby reduce its occurrence. The advice to IDU must be that they should use a new 
sterile syringe on each injecting episode [33]. Greater accessibility to syringe exchanges in 
Dublin would facilitate their cooperation with this advice, but the concerns of local 
communities who oppose such exchanges will need to be addressed through ongoing 
communication and education.  
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